Barclays’s Envision Healthcare Holdings Inc EVHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-40,000
Closed -$1.76M 7630
2018
Q2
$1.76M Sell
40,000
-30,800
-44% -$1.27M ﹤0.01% 2694
2018
Q1
$2.72M Hold
70,800
﹤0.01% 2163
2017
Q4
$2.45M Buy
+70,800
New +$2.48M ﹤0.01% 2261
2017
Q1
Sell
-30,492
Closed -$1.93M 7139
2016
Q4
$1.93M Sell
30,492
-100,570
-77% -$6.57M ﹤0.01% 2158
2016
Q3
$8.74M Buy
131,062
+10,521
+9% +$725K 0.01% 944
2016
Q2
$9.16M Sell
120,541
-262,858
-69% -$18.7M 0.01% 885
2016
Q1
$23M Buy
+383,399
New +$25.2M 0.04% 427
2015
Q1
Sell
-10,020
Closed -$1.02M 7363
2014
Q4
$1.02M Hold
10,020
﹤0.01% 3199
2014
Q3
$1.02M Buy
+10,020
New +$1.06M ﹤0.01% 3328

Other funds holding EVHC

Barclays's EVHC Position: Q4 2018 in Review

Barclays sold out of Envision Healthcare Holdings Inc (EVHC) in Q4 2018, closing a stake of 382,176 shares — an estimated $17.5M sold.

Barclays first reported a position in EVHC in Q3 2013 and held it in 21 quarters. The position peaked at $334M in Q1 2015. 4 funds tracked by Wall St. Rank hold EVHC as of Q4 2018.

  • Barclays reported no remaining Envision Healthcare Holdings Inc position as of Q4 2018 after selling out during the quarter.
  • Barclays sold 382,176 Envision Healthcare Holdings Inc shares in Q4 2018, an estimated $17.5M.
  • Barclays first reported a position in Envision Healthcare Holdings Inc in Q3 2013 and held it in 21 quarters.
  • Barclays's Envision Healthcare Holdings Inc position peaked at $334M in Q1 2015.
  • 4 funds tracked by Wall St. Rank held Envision Healthcare Holdings Inc as of Q4 2018.

Based on Barclays's 13F filing for Q4 2018, filed 14 Feb 2019.